DK33591D0 - - Google Patents
Info
- Publication number
- DK33591D0 DK33591D0 DK33591A DK33591A DK33591D0 DK 33591 D0 DK33591 D0 DK 33591D0 DK 33591 A DK33591 A DK 33591A DK 33591 A DK33591 A DK 33591A DK 33591 D0 DK33591 D0 DK 33591D0
- Authority
- DK
- Denmark
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK33591A DK33591D0 (fr) | 1991-02-27 | 1991-02-27 | |
AU13729/92A AU1372992A (en) | 1991-02-27 | 1992-02-27 | Novel insulin derivatives |
PCT/DK1992/000059 WO1992015611A1 (fr) | 1991-02-27 | 1992-02-27 | Nouveaux derives d'insuline |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK33591A DK33591D0 (fr) | 1991-02-27 | 1991-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK33591D0 true DK33591D0 (fr) | 1991-02-27 |
Family
ID=8092374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK33591A DK33591D0 (fr) | 1991-02-27 | 1991-02-27 |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1372992A (fr) |
DK (1) | DK33591D0 (fr) |
WO (1) | WO1992015611A1 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9316895D0 (en) * | 1993-08-13 | 1993-09-29 | Guy S And St Thomas Hospitals | Hepatoselective insulin analogues |
US6342225B1 (en) | 1993-08-13 | 2002-01-29 | Deutshces Wollforschungsinstitut | Pharmaceutical active conjugates |
CA2552043A1 (fr) | 2004-01-21 | 2005-08-04 | Novo Nordisk A/S | Conjugaison de peptides induite par la transglutaminase |
KR20150138251A (ko) * | 2013-03-15 | 2015-12-09 | 케이스 웨스턴 리저브 유니버시티 | 부위 2 인슐린 유사체 |
WO2018094388A1 (fr) * | 2016-11-21 | 2018-05-24 | Case Western Reserve University | Analogue d'insuline à action rapide à stabilité améliorée |
BR112020002364A2 (pt) | 2017-08-17 | 2020-09-01 | Novo Nordisk A/S | derivado de insulina, produto intermediário, uso de um derivado de insulina, e, métodos para o tratamento ou prevenção de diabetes, diabetes do tipo 1, diabetes do tipo 2, tolerância à glicose comprometida, hiperglicemia, dislipidemia, obesidade, síndrome metabólica, hipertensão, distúrbios cognitivos, aterosclerose, infarto do miocárdio, acidente vascular cerebral, distúrbios cardiovasculares, doença cardíaca coronariana, síndrome intestinal inflamatória, dispepsia, hipotensão ou úlceras gástricas, e para determinar a seletividade de um composto de insulina |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK119785D0 (da) * | 1985-03-15 | 1985-03-15 | Nordisk Gentofte | Insulinpraeparat |
PH25772A (en) * | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
AU616205B2 (en) * | 1988-07-20 | 1991-10-24 | Novo Nordisk A/S | Human insulin analogs and preparations containing them |
ATE120762T1 (de) * | 1989-04-20 | 1995-04-15 | Sinai School Medicine | Hepatospezifische insulin-analoga. |
DK158390D0 (da) * | 1990-07-02 | 1990-07-02 | Novo Nordisk As | Nye peptider |
-
1991
- 1991-02-27 DK DK33591A patent/DK33591D0/da not_active Application Discontinuation
-
1992
- 1992-02-27 AU AU13729/92A patent/AU1372992A/en not_active Abandoned
- 1992-02-27 WO PCT/DK1992/000059 patent/WO1992015611A1/fr active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1992015611A1 (fr) | 1992-09-17 |
AU1372992A (en) | 1992-10-06 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ATS | Application withdrawn |